We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




PSMA-PET Imaging Improves Outcomes for Patients with Recurrent Prostate Cancer

By MedImaging International staff writers
Posted on 28 Oct 2024
Print article
Image: A study has shown long-term benefits of PSMA-PET in patients with recurrent prostate cancer (Photo courtesy of 123RF)
Image: A study has shown long-term benefits of PSMA-PET in patients with recurrent prostate cancer (Photo courtesy of 123RF)

While prostate-specific membrane antigen positron emission tomography (PSMA-PET) has demonstrated enhanced sensitivity and specificity compared to traditional imaging techniques for detecting biochemical recurrent (BCR) prostate cancer, the long-term effects of a widespread shift to this imaging method remain uncertain. Now, a new study indicates that even with modest improvements in early detection, PSMA-PET imaging may enhance both the length and quality of life for patients dealing with recurrent prostate cancer.

In the study, researchers at the University of York’s Centre for Health Economics (York, UK) set out to evaluate the long-term outcomes of PSMA-PET imaging in comparison to conventional imaging strategies in patients with recurrent prostate cancer. This decision analytic modeling study simulated patient outcomes following initial definitive local therapy for BCR. The study utilized data from existing literature and a retrospective cohort study performed at two institutions. The primary analysis presumed modest advantages of earlier detection and treatment, while scenario analyses explored variables such as prostate-specific antigen (PSA) levels at the time of imaging and the differing outcomes of early versus delayed treatment. The main outcomes measured included the detection of metastases, prostate cancer-related deaths, and the gain in life-years and quality-adjusted life-years (QALYs).

The results from this decision analytic modeling study projected that employing PSMA-PET upfront for imaging in BCR prostate cancer would likely result in increased life-years and QALYs, along with a reduction in prostate cancer-related deaths. The clinical benefits were anticipated to be consistent across varying PSA levels. Furthermore, the advantages linked to early detection and the initiation of salvage therapies were sensitive to assumptions about the effectiveness of early treatment. Thus, the findings imply that with modest benefits from early detection, PSMA-PET imaging could potentially enhance both the duration and quality of life for patients with recurrent prostate cancer.

Related Links:
University of York’s Centre for Health Economics

New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Gold Member
X-Ray QA Meter
T3 RG Pro
Radiation Therapy Treatment Software Application
Elekta ONE
Ultrasound System
Aplio go

Print article
Radcal

Channels

Radiography

view channel
Image: The CT scanner prototype eliminates the need for physical compression of the breast (Photo courtesy of Quion Lowe and Lisa Dahm/U of A Cancer Center)

Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram

Breast cancer represents 15.5% of new cancer cases and 7% of cancer-related deaths in the United States. Approximately 13.1% of women will be diagnosed with breast cancer during their lifetime.... Read more

Ultrasound

view channel
Image: A prototype of the developed device (Photo courtesy of KTU)

Ultrasound Device Non-Invasively Improves Blood Circulation in Lower Limbs

Impaired blood circulation in the lower limbs is a common health issue among the elderly and is a significant complication of diabetes, often referred to as diabetic foot. This condition arises due to... Read more

General/Advanced Imaging

view channel
Image: The MEDRAD Centargo CT injection system has received FDA clearance (Photo courtesy of Bayer)

Automated Multi-Patient CT Injection System Reduces Patient Set-Up Time and Streamlines Workflows

Radiology departments are grappling with a shortage of radiology technologists alongside a growing demand for medical imaging. Consequently, radiology technologists are required to work more efficiently... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.